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Abstract
Acute myocardial infarction is a rare condition in young athletes. One of the causes could
be a hypercoagulable state due to congenital antithrombin III deficiency, together with
a prothrombotic state soon after strenuous physical training. We present the case of myocardial
reinfarction in young football player with antithrombin III deficiency, treated with primary
percutaneous coronary intervention and drug eluting stent, as well as the functional repercus-
sions of continuous intensive physical activity. (Cardiol J 2008; 15: 463–466)
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Case report
A 24-year-old active football player was admit-
ted to the coronary unit (ICU) with severe chest
pain that developed 1 hour after intensive physical
training and 2 hours prior to admission. Acute myo-
cardial infarction (MI) was diagnosed based on elec-
trocardiographic (ECG) changes, which showed ST
segment elevation of 4 mm in V1–V4 and recipro-
cal ST segment depression of 2 mm in DII, DIII and
aVF, with no Q waves. The levels of CK-MB and
troponin T were 25.0 and 0.117 ng/mL, respective-
ly. He had no risk factors, absent family history and
no previous anamnesis of cardiovascular disease.
He denied use of any steroids or protein supple-
ments. There were no abnormalities on physical
examination. His blood pressure was 130/80 mm Hg.
Laboratory data showed white blood cell count of
9.5 × 109/L, fibrinogen 2.37 g/L (2–4), C-reactive
protein 1.1 mg/L (0–6) and other parameters within
normal limits. He received a bolus dose of 10,000
units of unfractioned heparin, and emergent coro-
nary angiography was performed. Coronary angio-
graphy showed a total occlusion with thrombus and
TIMI 0 distal flow in the proximal portion of the left
anterior descendent coronary artery (LAD), which
was successfully treated with a Taxus stent. After
percutaneous coronary intervention (PCI), the pa-
tient became stable without chest pain and was di-
scharged on the fifth hospital day. Hematological
analyses performed two weeks after acute myocar-
dial infarction showed the following results: fibri-
nolysis activators 62% (60–120%); fibrinolysis in-
hibitors 55% (60–120%); D-dimmer 133 mg/mL
(< 250); antiphospholipid antibodies 8 SAU (0–20)
and antithrombin III (AT III) 0.13 (0.17–0.3 g/L).
Due to AT III deficiency, he was put on anticoagu-
lant therapy. Patient lipid profile before discharge
was: total cholesterol 9.5 mmol/L, LDL cholesterol
3.8 mmol/L, HDL cholesterol 1.2 mmol/L and trigly-
cerides 0.9 mmol/L. Echocardiography before di-
scharge showed apical hypokinesia with ejection frac-
tion of 62%, end diastolic dimension 62mm and hy-
pertrophy of the septum 16 mm. His therapy included
the beta blocker Bisoprolol 5 mg per day, anticoagu-
lant acenocoumarin (Sintrom) — according to inter-
national normalized ratio (INR) values, Plavix 75 mg
per day for one year and simvastatin 20 mg per day.
After this event he was asymptomatic and
he stopped anticoagulant therapy after 6 months,
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continuing active football playing and physical tra-
ining, regardless of his physician’s advice. Hema-
tological analyses were repeated 7 months after the
myocardial infarction and showed the following re-
sults: fibrinolysis activators 65% (60–120%); fibri-
nolysis inhibitors 58% (60–120%); D-dimmer
137 mg/mL (< 250); antiphospholipid antibodies
8 SAU (0–20) and AT III 0.12 (0.17–0.3 g/L). One
month after he stopped Plavix therapy (13 months
after MI), again 1 hour after intensive training, he
felt severe chest pain. He was admitted to an ICU
with ECG showing anteroseptal reinfarction with
ST segment elevation in V1–V3, Q waves in these
leads and ST segment depression in DII, DIII, aVF,
V5 and V6 (Fig. 1). The levels of CK-MB and tro-
ponin T were 22.0 and 0.113 ng/mL, respectively.
Emergent coronary angiography showed a total
occlusion of the Taxus stent with thrombus and
TIMI 0 distal flow in the proximal portion of LAD
which was successfully treated with in-stent dila-
tation (Fig. 2). After intervention, the patient beca-
me stable without chest pain and was discharged
on the sixth hospital day. Despite his physician’s
advice to reduce physical activity and active foot-
ball training, he still continues his training. Echo-
cardiography 6 months after reinfarction showed
ejection fraction 50%, septum 10 mm, and hypoki-
nesia of the distal septum and apical wall. One-day
rest/stress Tc-99m sestamibi myocardial perfusion
gated SPECT imaging (MPI) was performed 10 mon-
ths after the reinfarction. Treadmill stress test was
negative, with 100% cardio respiratory activity,
MET 11, and 70% of maximal HR achieved, witho-
ut chest pain or dyspnoea. MPI showed severe
fixed perfusion defect at the anterior, antero-septal
and apical wall (vascular region LAD), which takes
Figure 1. Myocardial perfusion imaging showed severe fixed perfusion defect at the anterior, antero-septal and
apical wall (vascular region left anterior descending), which takes 42% of left ventricular myocardium, with 10% of
peri-infarction hibernated myocardium. Left ventricular function is severely reduced, with ejection fraction 35% and
large remodelled left ventricle with increased left ventricular volumes.
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42% of left ventricular myocardium, with 10% of
peri-infarction hibernated myocardium. Left ventri-
cular function was severely reduced, with ejection
fraction 35% and large remodelled left ventricle
with increased left ventricular volumes. Coronary
angiography showed patent Taxus stent (no in-stent
restenosis and no changes in other coronary vessels).
The patient was put on intensive therapy for heart
failure (ACE-inhibitor — enalapril 20 mg per day,
beta-blocker — carvedilol 2.5 mg twice per day, anti-
coagulant acenocoumarin (Sintrom) according to INR
values, atorvastatin 20 mg per day). He was advised
to stop football playing and intense physical activity.
Discussion
To our knowledge, this is the first report of
myocardial reinfarction in a young athlete with AT III
deficiency treated with a Taxus stent. He has no
traditional risk factors and normal C-reactive pro-
tein and fibrinogen values. Acute myocardial infarc-
tion is rare in teenagers and young adults. Myocar-
dial infarction in young adults can be broadly di-
vided into two groups: those with angiographically
normal coronary arteries and those with corona-
ry artery disease of different etiology [1]. The pa-
thophysiology of myocardial infarction in the pre-
sence of “normal” coronary arteries remains un-
clear but can be explained based on coronary
artery thrombosis, embolisation, spasm, or a com-
bination of these processes. Coronary thrombo-
sis can be seen in hypercoagulable states such as
in the nephrotic syndrome, antiphospholipid syn-
drome, and protein S and factor XII deficiencies
[1–4]. A reduction in the concentration of antith-
rombin III is particularly responsible for the
thrombophilic tendency in most of the subjects.
Factor V Leiden mutation is associated with
a procoagulant state and has been reported to
result in MI in young people [1].
Figure 2. A. Angiographic presentation of proximal left anterior descending thrombosis during the first myocardial
infarction; B. A view of ballooning to implant the stent; C. Final view of left anterior descending and diagonal branch
subsequent to stenting.
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Coronary artery spasm causing MI is recogni-
sed with both the recreational and therapeutic use
of cocaine, alcohol binges and amphetamine use.
Systemic collagen tissue disorders, like systemic
lupus are considered one for the rare factors for MI
in young adults, caused by increased inflammatory
response.
Myocardial infarction in young adults might be
the result of premature atherosclerosis due to ge-
netic polymorphisms of apoL, hyperhomocysteine-
mia, and other procoagulant disorders [5]. Mutations
in the gene encoding the low-density lipoprotein
receptor produce familial hypercholesterolemia,
clinically characterised by high serum cholesterol
(low-density lipoprotein fraction) concentrations,
xanthomas and premature atherosclerosis. Other
risk factors include smoking, hypertension, insulin
resistance, obesity and a family history of prema-
ture cardiovascular events. Anomalous origins of
either left or right coronary arteries have been as-
sociated with myocardial infarction and are related
to acute angulations and compression of the artery
at its origin or along its course.
Antithrombin III is a potent inhibitor of the
coagulation cascade. Congenital AT III deficiency
is an autosomal dominant disorder. This condition
leads to an increased risk of venous and arterial
thrombosis, with an onset of clinical manifestations
typically appearing in young adulthood. Once a pa-
tient with congenital AT III deficiency has develo-
ped thrombosis, anticoagulation is indicated. Pro-
gnosis depends on 3 variables: the degree of the
deficiency, the nature of the observed clot and the
number of clots seen [5, 6].
Acute myocardial infarction in young athletes
can be caused by several mechanisms. Clinical ob-
servations suggest that continuous, prolonged,
moderate-intensity exercise is associated with
markedly elevated IL-6 and acute-phase reactant
concentrations, peripheral tissue damage and signifi-
cant changes in serum lipid levels. Strenuous and/or
prolonged physical activity leads to muscle and
other tissue damage and thereby induces an inflam-
matory response characterized by secretion of pro-
inflammatory cytokines, chemokines and other
mediators of inflammation. In addition, strenuous
and/or prolonged physical activity perturbs interme-
diary metabolism and produces a wide variety of
changes in the plasma concentrations of metaboli-
tes, including those of lipids and lipoproteins, which
in general appear to be antiatherogenic. In contrast
to what is observed with exercise, HDL particles lose
their protective enzyme, paraoxonase, and platelet-
activating factor, acetylhydrolase, whereas they con-
comitantly develop a marked increase in their
content of serum amyloid A and ceruloplasmin, all
changes that result in an overall diminution of their
antiatherogenic properties. In our patient, white blo-
od cells, C-reactive protein, fibrinogen, as well as lipid
values at the acute phase, were within normal limits.
In the current case, we can assume the casual
relation between AT III deficiency, clopidogrel and
oral anticoagulation therapy discontinuation and late
drug eluting stent thrombosis, as well as the pro-
thrombotic and proinflamatory effects of strenuous
physical activity on coronary events, which all lead
to acute coronary thrombosis. In the future, further
studies are warranted to clarify this issue in terms
of etiological and pathophysiological aspects as well
as preventive and treatment measures in this spe-
cific population.
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